Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,347
Closed -$441K 131
2025
Q4
$441K Hold
1,347
0.1% 93
2025
Q3
$380K Hold
1,347
0.09% 92
2025
Q2
$376K Hold
1,347
0.09% 88
2025
Q1
$420K Hold
1,347
0.11% 86
2024
Q4
$351K Hold
1,347
0.1% 87
2024
Q3
$434K Hold
1,347
0.12% 78
2024
Q2
$421K Hold
1,347
0.13% 77
2024
Q1
$383K Hold
1,347
0.12% 80
2023
Q4
$388K Hold
1,347
0.13% 78
2023
Q3
$362K Hold
1,347
0.13% 80
2023
Q2
$299K Hold
1,347
0.1% 84
2023
Q1
$326K Hold
1,347
0.12% 82
2022
Q4
$354K Hold
1,347
0.12% 81
2022
Q3
$304K Hold
1,347
0.12% 86
2022
Q2
$328K Buy
1,347
+347
+35% +$85K 0.12% 86
2022
Q1
$242K Hold
1,000
0.08% 96
2021
Q4
$225K Hold
1,000
0.08% 95
2021
Q3
$213K Hold
1,000
0.06% 97
2021
Q2
$244K Hold
1,000
0.06% 120
2021
Q1
$249K Hold
1,000
0.06% 118
2020
Q4
$230K Hold
1,000
0.07% 116
2020
Q3
$254K Hold
1,000
0.09% 107
2020
Q2
$236K Hold
1,000
0.08% 108
2020
Q1
$203K Hold
1,000
0.09% 111
2019
Q4
$241K Buy
+1,000
New +$220K 0.07% 108
2018
Q4
Sell
-1,000
Closed -$207K 114
2018
Q3
$207K Buy
+1,000
New +$197K 0.05% 120

Other funds holding AMGN

Hourglass Capital's AMGN Position: Q1 2026 in Review

Hourglass Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,347 shares — an estimated $441K sold.

Hourglass Capital first reported a position in AMGN in Q3 2018 and held it in 26 quarters. The position peaked at $441K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hourglass Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Hourglass Capital sold 1,347 Amgen shares in Q1 2026, an estimated $441K.
  • Hourglass Capital first reported a position in Amgen in Q3 2018 and held it in 26 quarters.
  • Hourglass Capital's Amgen position peaked at $441K in Q4 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hourglass Capital's 13F filing for Q1 2026, filed 4 May 2026.